PubRank

Randy L Jensen

Author PubWeight™ 46.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res 2007 1.31
2 Se-methylselenocysteine sensitizes hypoxic tumor cells to irinotecan by targeting hypoxia-inducible factor 1alpha. Cancer Chemother Pharmacol 2010 1.21
3 Hypoxia-regulated protein expression, patient characteristics, and preoperative imaging as predictors of survival in adults with glioblastoma multiforme. Cancer 2008 1.18
4 Early growth response gene-1 regulates hypoxia-induced expression of tissue factor in glioblastoma multiforme through hypoxia-inducible factor-1-independent mechanisms. Cancer Res 2006 1.13
5 Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007 1.13
6 Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg 2009 1.12
7 Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol 2006 1.09
8 Transient postictal MRI changes in patients with brain tumors may mimic disease progression. Surg Neurol 2006 1.08
9 Identification of hypoxia-induced genes in a malignant glioma cell line (U-251) by cDNA microarray analysis. Neurosurg Rev 2007 1.04
10 Safety and feasibility of convection-enhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery 2005 1.04
11 WHO Grade II and III supratentorial hemispheric ependymomas in adults: case series and review of treatment options. J Neurooncol 2008 1.03
12 Variations of disseminated choroid plexus papilloma: 2 case reports and a review of the literature. Surg Neurol 2006 1.03
13 Molecular genetics of meningiomas. Neurosurg Focus 2005 1.00
14 Subependymomas: an analysis of clinical and imaging features. Neurosurgery 2006 1.00
15 Surgical considerations regarding giant dilations of the perivascular spaces. J Neurosurg 2004 1.00
16 Role of stereotactic radiosurgery in the treatment of brain metastases. Am J Clin Oncol 2005 0.96
17 Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 2004 0.95
18 Biochemotherapy of metastatic melanoma in patients with or without recently diagnosed brain metastases. Cancer 2007 0.94
19 Celecoxib inhibits meningioma tumor growth in a mouse xenograft model. Cancer 2007 0.93
20 Oligodendroglioma and juvenile pilocytic astrocytoma presenting as synchronous primary brain tumors. Case report with histological and molecular differentiation of the tumors and review of the literature. J Neurosurg 2004 0.92
21 Treatment-related brain tumor imaging changes: So-called "pseudoprogression" vs. tumor progression: Review and future research opportunities. Surg Neurol Int 2013 0.92
22 Comparison of 18F-fluorodeoxyglucose and 18F-fluorothymidine PET in differentiating radiation necrosis from recurrent glioma. Clin Nucl Med 2012 0.92
23 In vivo characterization of several rodent glioma models by 1H MRS. NMR Biomed 2011 0.92
24 A comparison of the cell lines used in meningioma research. Surg Neurol 2008 0.91
25 ELTD1, a potential new biomarker for gliomas. Neurosurgery 2013 0.91
26 Aberrant signaling pathways in meningiomas. J Neurooncol 2010 0.91
27 Preliminary use of differential scanning calorimetry of cerebrospinal fluid for the diagnosis of glioblastoma multiforme. J Neurooncol 2011 0.90
28 A practical review of prognostic correlations of molecular biomarkers in glioblastoma. Neurosurg Focus 2015 0.90
29 A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation. J Neurosurg 2008 0.89
30 Conformity of LINAC-based stereotactic radiosurgery using dynamic conformal arcs and micro-multileaf collimator. Int J Radiat Oncol Biol Phys 2008 0.88
31 Meningioma of the jugular foramen: glomus jugulare mimic and surgical challenge. Laryngoscope 2004 0.88
32 Peritumoral edema after stereotactic radiosurgery for intracranial meningiomas and molecular factors that predict its development. J Neurooncol 2007 0.88
33 Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery. Cancer 2008 0.87
34 Experimental validation of 5 in-silico predicted glioma biomarkers. Neuro Oncol 2013 0.86
35 New approaches for the treatment of refractory meningiomas. Cancer Control 2003 0.85
36 A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results. Phys Med Biol 2010 0.85
37 Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007. Neuro Oncol 2013 0.84
38 Differential scanning calorimetry of gliomas: a new tool in brain cancer diagnostics? Neurosurgery 2013 0.82
39 Stereotactic radiosurgery eligibility and selection bias in the treatment of glioblastoma multiforme. J Neurooncol 2010 0.81
40 Hypoxia-inducible factor-1 and associated upstream and downstream proteins in the pathophysiology and management of glioblastoma. Neurosurg Focus 2014 0.81
41 Silencing of HIF-1alpha by RNA interference in human glioma cells in vitro and in vivo. Methods Mol Biol 2009 0.81
42 Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas. Neurosurg Focus 2015 0.79
43 Phase I trial of verubulin (MPC-6827) plus carboplatin in patients with relapsed glioblastoma multiforme. J Neurooncol 2012 0.79
44 The role of intra-cerebrospinal fluid treatment and prophylaxis in patients with solid tumors. Semin Oncol 2009 0.77
45 Multimodality management of brain metastases in metastatic melanoma patients. Expert Rev Anticancer Ther 2007 0.77
46 Inflammatory response and meningioma tumorigenesis and the effect of cyclooxygenase-2 inhibitors. Neurosurg Focus 2007 0.77
47 Chronic suppressive therapy with calcium channel antagonists for refractory meningiomas. Neurosurg Focus 2007 0.77
48 RNA interference targeting hypoxia-inducible factor 1α via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model. J Neurosurg 2014 0.76
49 Calcium channel antagonists augment hydroxyurea- and ru486-induced inhibition of meningioma growth in vivo and in vitro. Neurosurgery 2006 0.76
50 Image guidance for brain metastases resection. Surg Neurol Int 2012 0.76
51 Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note. Neurosurg Focus 2003 0.75
52 Intracerebral amyloidoma can mimic high-grade glioma on magnetic resonance imaging and spectroscopy. Arch Neurol 2006 0.75
53 Surgical strategies for recurrent craniofacial meningiomas. Neurosurgery 2006 0.75
54 Pleomorphic liposarcoma originating from intracranial dura mater. J Neurooncol 2009 0.75
55 Ubiquitous expression of cyclooxygenase-2 in meningiomas and decrease in cell growth following in vitro treatment with the inhibitor celecoxib: potential therapeutic application. J Neurosurg 2005 0.75
56 Primary spinal yolk sac tumor with brain metastasis: case report and review of the literature. J Neurooncol 2006 0.75